Surgery partners, inc. (SGRY)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Aug'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Sep'14
Revenue from Contract with Customer, Including Assessed Tax

1,855,600

1,831,400

1,805,400

1,785,800

1,777,000

1,771,500

1,872,900

1,614,564

1,466,317

1,341,200

1,054,601

1,163,219

1,164,547

1,145,438

1,102,759

1,059,676

1,002,822

959,891

772,872

0

0

0

Operating expenses:
Salaries and benefits

561,200

550,000

540,700

532,800

534,200

534,700

570,600

500,391

456,313

416,500

0

356,407

360,176

-

339,681

320,029

288,420

261,685

207,148

0

0

0

Supplies

522,200

507,900

499,200

493,100

490,900

490,300

516,700

444,656

397,540

354,300

0

283,906

276,737

-

262,017

256,487

248,659

242,083

193,679

0

0

0

Professional and medical fees

166,500

154,800

148,200

144,600

144,900

145,500

152,400

131,698

117,575

103,000

0

84,929

82,656

-

79,253

75,630

71,497

66,583

50,464

0

0

0

Lease expense

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease expense

-

-

84,800

85,100

-

86,700

92,800

80,300

72,174

64,400

0

53,939

53,339

-

50,293

48,300

46,322

44,848

36,918

0

0

0

Other operating expenses

111,500

109,300

106,400

104,900

104,300

104,200

110,800

95,755

85,550

75,600

0

64,860

63,533

-

58,879

57,104

55,358

54,127

43,320

0

0

0

Cost of revenues

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of revenues

-

-

1,379,300

1,360,500

-

1,361,400

1,443,300

1,252,800

1,129,152

1,013,800

0

844,041

836,441

-

790,123

757,550

710,256

669,326

531,529

0

0

0

Total operating expenses

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative expenses

89,700

88,600

88,800

88,300

91,100

93,600

98,900

92,104

84,659

76,000

0

67,222

63,590

-

63,253

59,504

56,327

55,992

41,682

0

0

0

Depreciation, Depletion and Amortization

79,500

76,500

74,300

72,900

70,500

67,400

71,200

61,775

56,492

51,900

0

42,806

41,091

-

37,990

36,888

35,651

34,545

28,372

0

0

0

Provision for doubtful accounts (see Note 1)

-

-

-

-

-

-

-

-

-

28,800

0

28,258

26,014

-

23,460

20,786

22,265

23,578

17,432

0

0

0

Income from equity investments

10,200

10,200

9,200

8,700

9,000

8,900

9,600

8,548

7,100

6,400

0

5,176

5,206

-

3,918

4,071

3,828

3,777

2,866

0

0

0

Gain (Loss) On Disposition Of Assets And Deconsolidation

1,500

4,400

-9,000

-21,000

-32,400

-31,800

-15,800

-3,299

-504

-1,700

0

-2,831

-3,757

-

-1,122

-1,711

2,526

2,097

1,530

0

0

0

Transaction and integration costs

22,500

19,000

19,500

23,200

28,700

31,700

31,300

26,559

17,763

13,100

0

7,482

5,903

-

9,384

8,769

16,086

17,920

15,222

0

0

0

Impairment charges

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Loss on debt extinguishment

-

-

0

0

-

-

0

0

-

-18,200

0

-3,595

-3,595

-

-27,978

-24,383

-24,383

-16,102

0

0

0

0

Litigation settlement

0

-

-

-

0

-

-

-

-

0

-

0

-

-

-

0

-

-

-

-

-

-

Gain on acquisition escrow release

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Electronic health records incentive expense (income)

-

-

-

-

-

-

-

-

-

-

-

615

456

-

1,599

1,906

1,854

1,761

-107

0

0

0

Other income

-2,900

-1,400

-600

-1,700

-3,500

-3,700

-3,600

-2,898

-698

-500

0

-44

-4

-

-72

-402

-455

-525

-356

0

0

0

Total operating expenses

0

-

1,693,118

1,687,518

0

-

1,650,934

0

0

-

-

972,505

960,624

-

953,555

909,046

862,139

815,137

629,592

0

0

0

Operating income

209,800

235,900

112,200

98,200

86,200

77,800

222,000

163,540

157,779

158,300

0

190,714

203,923

-

149,204

150,630

140,683

144,754

143,280

0

0

0

Tax receivable agreement expense

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on amendment to tax receivable agreement

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Tax receivable agreement (expense) benefit

-

-

-

-

-

-

-

-

-

0

-

-

-

-

0

-

-

-

0

-

-

-

Interest expense, net

-184,000

-178,900

-173,700

-165,200

-154,700

-147,000

-156,100

-137,118

-126,818

-117,700

0

-102,965

-103,600

-

-97,336

-97,434

-97,377

-100,980

-89,770

0

0

0

(Loss) income before income taxes

25,800

54,600

-63,900

-69,400

-70,900

-69,200

92,300

68,122

72,661

82,300

0

84,016

96,590

-

-71,776

-66,715

-76,605

-76,137

53,510

0

0

0

Income tax (benefit) expense

-7,400

9,500

20,600

24,000

26,300

26,400

82,600

56,071

53,283

53,600

0

5,534

7,442

-

-154,854

-149,243

-149,319

-148,982

16,329

0

0

0

Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

33,200

45,100

-84,500

-93,400

-97,200

-95,600

9,700

12,051

19,378

28,700

0

78,482

89,148

-

83,078

82,528

72,714

72,845

37,181

0

0

0

Less: Net income attributable to non-controlling interests

115,400

119,900

118,800

115,200

111,100

110,100

109,000

94,826

87,124

81,700

0

71,184

75,259

-

73,747

73,981

71,713

71,416

59,399

0

0

0

Net loss attributable to Surgery Partners, Inc.

-82,200

-74,800

-203,300

-208,600

-208,300

-205,700

-99,300

-82,775

-67,746

-53,000

0

7,298

13,889

-

9,331

8,547

1,001

1,429

-22,218

0

0

0

Less: Amounts attributable to participating securities

36,700

35,700

34,900

34,000

33,100

32,400

50,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to common stockholders

-118,900

-110,500

-238,200

-242,600

-241,400

-238,100

-149,300

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per share attributable to common stockholders - basic and diluted (in USD per share)

-

-

-

-

-

-

-

-

-

-1.39

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average common shares outstanding - basic and diluted (shares)

-

-

-

-

-

-

-

-

-

48,319

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per share attributable to common stockholders
Basic (in USD per share)

-0.76

-

-0.51

-0.59

-0.60

-

-0.61

-0.57

-0.53

-

-

-0.09

-0.06

-

-0.05

0.04

-0.15

0.52

-0.10

-0.17

-0.21

-0.22

Diluted (in USD per share)

-0.76

-

-0.51

-0.59

-0.60

-

-0.61

-0.57

-0.53

-

-

-0.09

-0.06

-

-0.05

0.04

-0.15

0.52

-0.10

-0.17

-0.21

-0.22

Weighted average common shares outstanding
Basic (shares)

48,472

-

48,310

48,291

48,047

-

48,038

48,016

48,007

-

-

48,145

48,019

-

48,019

48,019

48,017

48,102

32,054

32,054

32,054

31,698

Diluted (shares)

48,472

-

48,310

48,291

48,047

-

48,038

48,016

48,007

-

-

48,145

48,019

-

48,019

48,129

48,017

53,695

32,054

32,054

32,054

31,698

Contingent acquisition expense

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-